
Increase in incidence of dysmenorrhea, which is attributed to changing lifestyle, addiction to smoking and alcohol, hormonal changes and physical and mental stress, has created the need for effective treatment methods which favors the growth of this market. Several pharmaceutical companies are introducing medications and prescribed drugs for the treatment. Considering this fact, a study titled "Dysmenorrhea- Pipeline Insight, 2017" has been added to the broad archive of Market Research Hub (MRH), which provides comprehensive insights about the pipeline drugs across this Dysmenorrhea. Also, this report provides information on the therapeutic development for Dysmenorrhea, dealing with all the pipeline drugs and relative analysis at various stages covering all clinical, pre-clinical as well as discovery products.